874
Eighty-two patients with various malignancies who received imipenem/cilastatin 143 times for neutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
 ( potential therapeutic event: received ,  Eighty-two patients with various malignancies: Subject, Eighty-two: Subject.Population, various malignancies: Subject.Disorder, imipenem/cilastatin 143 times for neutropenic fever: Treatment, imipenem: Treatment.Drug, cilastatin: Treatment.Drug, neutropenic fever: Treatment.Disorder, imipenem: Combination.Drug, cilastatin: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( potential therapeutic event: received ,  Eighty-two patients with various malignancies: Subject, Eighty-two: Subject.Population, various malignancies: Subject.Disorder, imipenem/cilastatin 143 times for neutropenic fever: Treatment, imipenem: Treatment.Drug, cilastatin: Treatment.Drug, neutropenic fever: Treatment.Disorder, imipenem: Combination.Drug, cilastatin: Combination.Drug) 